Last Updated on February 25, 2024 by The Health Master
Gujarat FDCA
In the ever-evolving landscape of pharmaceutical regulations, Gujarat FDCA takes a pioneering step towards digital transformation.
The Gujarat Food and Drugs Control Administration (FDCA) has announced the online availability of Non-Conviction Certificates (NCC) and Performance Certificates (PC) for pharmaceutical companies, marking a significant stride in the run-up to the 10th Vibrant Gujarat Global Investor Summit (VGGS)-2024.
Introduction
The Gujarat FDCA’s initiative is a testament to the state’s commitment to modernizing its drug regulatory system.
NCC and PC, crucial documents in the pharmaceutical industry, will now be accessible online, streamlining the procurement process and ensuring efficiency in the delivery of essential medicines.
10th Vibrant Gujarat Global Investor Summit-2024
Scheduled between January 11 and 13, 2024, the 10th VGGS-2024 is the state government’s flagship investment summit after a five-year hiatus.
This sets the stage for the announcement of online certificates, enhancing the Ease of Doing Business (EoDB) in the pharmaceutical sector.
Related article: Non Conviction and Performance Certificates online soon: FDCA Gujarat
Online Availability of Certificates
The move to make NCC and PC available online aligns with the broader goal of strengthening the drug regulatory system in Gujarat.
Dr. H G Koshia, Commissioner of Gujarat FDCA and Pharma Guardian Officer, emphasizes that this digital transition aims to simplify the procurement process, particularly through government tenders.
Impact on Medicine Procurement Process
The seamless availability of NCC and PC online is expected to revolutionize the procurement of medicines.
Traditionally tied to government tenders, the process will become less time-consuming, offering a more efficient and streamlined approach.
Gujarat FDCA’s Initiatives
The online mechanism for NCC and PC issuance is part of Gujarat FDCA’s broader m-governance program.
Dr. Koshia highlights that this initiative will merge various online platforms into one, offering real-time access and expediting application status checks.
Ease of Doing Business (EoDB)
In government tenders, NCC plays a pivotal role for manufacturers, particularly Micro, Small, and Medium Enterprises (MSMEs).
The declaration in the prescribed proforma ensures that the licensee has not faced convictions under the Drugs and Cosmetics (D&C) Act, 1940 and Rules 1945.
Gujarat’s Leadership in Online Licenses
Gujarat has already made history by becoming the first state in the country to issue online licenses to allopathic medicines through the FDCA-mDMLA mobile app.
Launched on Good Governance Day, this app consolidates various license-related functions, offering unprecedented accessibility to stakeholders.
Role of Gujarat FDCA
Dr. Koshia proudly announces Gujarat FDCA’s achievement, stating that the mobile app covers 24 categories, including online Extended Licensing Node (XLN), drug manufacturing license application (DMLA), iDMLA, COSMLA, AYUMLA, and CERTIFICATE functions.
Mobile App for m-Governance
This mobile application, designed for manufacturers and retailers, is a strategic move towards accountability, transparency, inclusivity, uniformity, and timeliness.
The app caters not only to allopathic medicines but also extends support to ayurvedic medicine and cosmetic manufacturers.
Extension to Ayurvedic Medicine and Cosmetics
The inclusivity of ayurvedic medicine and cosmetic manufacturers signifies Gujarat FDCA’s commitment to holistic e-governance.
The mobile app aims to facilitate operations, services, and information access for more than 6,000 manufacturers and 52,000 drug sellers in the state.
Gujarat’s First-Mover Advantage
Dr. Koshia highlights that Gujarat FDCA’s pioneering efforts extend beyond online certificates, emphasizing the app’s direct benefits to stakeholders.
The ease of doing business for thousands of manufacturers and sellers becomes a reality, thanks to the state’s proactive approach.
Categories Covered by the Mobile App
The comprehensive coverage of 24 categories within the mobile app underscores Gujarat’s commitment to delivering a one-stop solution.
Whether it’s extended licensing, drug manufacturing, or certification, the app simplifies complex processes, setting a benchmark for other states.
Benefits for Stakeholders
Stakeholders, including manufacturers and retailers, stand to gain significantly from this digital leap.
The mobile app ensures that related operations, services, and information are accessible anytime, anywhere, aligning with the broader principles of EoDB.
Future Implications
The digital initiatives undertaken by Gujarat FDCA pave the way for potential advancements in drug regulatory practices.
As the first state to embrace such innovations, Gujarat could serve as a benchmark for others, encouraging a nationwide shift towards modernization.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
FAQs
- Q: How does the online availability of NCC and PC benefit pharmaceutical companies? A: The online availability streamlines the procurement process, making it more efficient and less time-consuming for pharmaceutical companies participating in government tenders.
- Q: What is the significance of the FDCA-mDMLA mobile app? A: The mobile app consolidates various license-related functions, offering real-time access and benefits to over 6,000 manufacturers and 52,000 drug sellers in Gujarat.
- Q: How does the NCC contribute to Ease of Doing Business (EoDB)? A: In government tenders, NCC is a crucial requirement, ensuring that manufacturers have not been convicted under the Drugs and Cosmetics Act, promoting transparency and accountability.
- Q: What categories are covered by the FDCA-mDMLA mobile app? A: The mobile app covers 24 categories, including extended licensing, drug manufacturing, certification, and functions related to ayurvedic medicine and cosmetics.
- Q: What is Gujarat’s role in the future of drug regulatory practices in India? A: Gujarat, as a pioneer in online certifications and mobile app initiatives, could set a benchmark for other states, encouraging a nationwide shift towards modernization.
FDCA Gujarat takes action against Pharma Companies
Non Conviction and Performance Certificates online soon: FDCA Gujarat
FDCA Commissioner inaugurates Cadila’s API Plant in Gujarat
Regulatory Practices: Gujarat FDCA Collaborates with USFDA for Strengthening
CDSCO Directs GSK to Submit Data for Belantamab Mafodotin Trial
NPPA’s Directive: Streamlining Drug Formulation Pricing
Govt Job: For M.Pharm, Pharm.D under (IPC) Indian Pharmacopoeia Commission
UK MHRA’s Revolutionary International Recognition Procedure
Drug recall: Benzocaine Topical Anesthetic Spray recalled Due to this reason
DCA Telangana’s Battle Against Spurious Drugs
USFDA issued Form 483 with 5 observations to Torrent
National Single Window System for Medical Devices
Unveiling the Top 20 Most Expensive Drugs in the World
The Need for Parallel Drug Approval in India: OPPI’s Urgent Plea
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: